The DOI matches its Crossref record.
Clinical outcomes with contemporary endovascular therapy of iliac artery occlusive disease
Abstract
Objectives: We sought to evaluate the clinical outcomes of a consecutive series of patients treated for iliac artery occlusive disease (IAOD) using contemporary endovascular technology and techniques. Background: As an increasingly complex spectrum of IAOD is treated using endovascular revascularization, there is a need to examine the rates of acute procedural success, complications, and patency to validate the role of an endovascular‐first approach to revascularization in contemporary practice. Methods: All patients with IAOD who were treated using endovascular therapy between September 2005 and September 2010 were identified from a prospectively collected database. Baseline patient characteristics, anatomic details, procedural data, and clinical outcomes were assessed retrospectively. Patency and mortality rates were estimated with the Kaplan–Meier method. Results: A total 59 patients underwent 62 procedures. Trans‐Atlantic Inter‐Society Consensus (TASC) II types B, C, and D disease accounted for 59%, 7%, and 37% of patients, respectively. The procedure was technically successful in 60 of 62 cases (97%) with no procedure‐related mortality. Major complications occurred in five procedures (8%). The mean (±standard deviation) duration of follow‐up was 2.3 ± 1.4 years. In patients with a successful revascularization, primary and secondary patency rates were 86% and 94% at 1 year, and 77% and 91% at 2 years, respectively. The TASC II classification of disease did not predict the rate of acute technical success or medium‐term patency rates. Conclusions: The acute and medium‐term clinical outcomes of this series of patients with anatomically complex IAOD support the current paradigm of an endovascular‐first approach to revascularization. © 2012 Wiley Periodicals Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In our retrospective analysis, we observed that although the number of samples we analyzed was higher than what is normally reported in the literature for this type of treatment, the lack of randomization and the absence of a control group might account for some of the limitations of the investigation [19,20].”
From Evaluation of Chitosan-Based Axiostat as Hemostatic Dressing for Endovascular Procedures in Patients with Leriche Syndrome on Anticoagulant Therapy (2025) · cites this paper as [20]
In the citing paper
“In our retrospective analysis, we observed that although the number of samples we analyzed was higher than what is normally reported in the literature for this type of treatment, the lack of randomization and the absence of a control group might account for some of the limitations of the investigation [19,20].”
From Evaluation of Chitosan-Based Axiostat as Hemostatic Dressing for Endovascular Procedures in Patients with Leriche Syndrome on Anticoagulant Therapy (2025) · cites this paper as [20]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 28
- 10.1016/j.jvs.2010.10.069 · DOI
- 10.1016/j.jvs.2006.02.051 · doi:10.1016/j.jvs.2006.02.051
- 10.1002/ccd.20703 · doi:10.1002/ccd.20703
- 10.1016/j.jvs.2010.08.073 · doi:10.1016/j.jvs.2010.08.073
- 10.1016/j.jvs.2010.01.092 · DOI
- Nishibe T, 2009, Hybrid surgical and endovascular therapy in multifocal peripheral TASC D lesions: Up to three‐year follow‐up, J Cardiovasc Surg (Torino), 50, 493
- 10.1002/ccd.22403 · doi:10.1002/ccd.22403
- Schrijver AM, 2010, Hybrid procedures for peripheral obstructive disease, J Cardiovasc Surg (Torino), 51, 833
- 10.1007/s00270-009-9566-y · doi:10.1007/s00270-009-9566-y
- 10.1016/j.jvs.2005.10.074 · doi:10.1016/j.jvs.2005.10.074
- 10.1016/j.jvs.2009.01.035 · DOI · Paper page
- 10.1016/j.jvs.2008.11.054 · doi:10.1016/j.jvs.2008.11.054
- 10.1007/s00330-005-2736-7 · doi:10.1007/s00330-005-2736-7
- 10.1007/s00270-004-0086-5 · doi:10.1007/s00270-004-0086-5
- 10.1080/00015458.2006.11679868 · doi:10.1080/00015458.2006.11679868
- 10.1007/s00270-002-1877-1 · doi:10.1007/s00270-002-1877-1
- 10.1007/s00270-008-9386-5 · DOI
- 10.1007/s002709900388 · doi:10.1007/s002709900388
- 10.1016/j.jvs.2005.09.034 · DOI · Paper page
- 10.1007/s00270-009-9691-7 · DOI
- 10.1016/S0002-9343(01)00727-6 · doi:10.1016/s0002-9343(01)00727-6
- 10.1583/1545-1550(2002)009<0067:LTROSF>2.0.CO;2 · doi:10.1583/1545-1550(2002)009<0067:ltrosf>2.0.co;2
- 10.1148/radiology.194.3.7862973 · doi:10.1148/radiology.194.3.7862973
- 10.1002/ccd.10658 · doi:10.1002/ccd.10658
- 10.1016/j.jvs.2006.12.037 · DOI · Paper page
- Surmely JF, 2006, New concept for CTO recanalization using controlled antegrade and retrograde subintimal tracking: The CART technique, J Invasive Cardiol, 18, 334
- 10.1016/S0741-5214(97)70053-3 · DOI · Paper page
- Dormandy JA, 2000, Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter‐Society Consensus (TASC), J Vasc Surg, 31, S1
Cited by
Perri, P., Curcio, F., De Luca, M., Piro, P., Trombino, S., & Cassano, R. (2025) · Pharmaceuticals · doi:10.3390/ph18040584 · Cited by 6
Metadata
- Authors
- Dattilo, P. B., Tsai, T. T., Garcia, J. A., Allshouse, A., & Casserly, I. P.
- Venue
- Catheterization and Cardiovascular Interventions
- Publisher
- Wiley
- Published
- 2012-03-14
- Volume
- 80
- Issue
- 4
- Pages
- 644-654
- ISSN
- 1522-1946
- 1522-726X
- Cited by
- 13
- References
- 0
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical outcomes with contemporary endovascular therapy of iliac artery occlusive disease. https://app.cochat.ai/papers/10.1002/ccd.23469
- The paper
- Dattilo, P. B., Tsai, T. T., Garcia, J. A., Allshouse, A., & Casserly, I. P. (2012). Clinical outcomes with contemporary endovascular therapy of iliac artery occlusive disease. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.23469
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.